Canada · Health Canada Drug Product Database

PROLAX - PWS

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 33648
DIN: 02147785
Form: Powder For Solution
Company as listed by source: RIVEX PHARMA INC.
Source status: Cancelled Post Market (2007-10-15)
Source last updated: 2025-03-22

Source-listed ingredients

POLYETHYLENE GLYCOL 3350 — 14.75 G — per 1 PCK
SODIUM SULFATE — 1.42 G — per 1 PCK
SODIUM BICARBONATE — 420 MG — per 1 PCK
SODIUM CHLORIDE — 370 MG — per 1 PCK
POTASSIUM CHLORIDE — 190 MG — per 1 PCK

These values do not establish equivalence or a dose recommendation.

Packages

10 Sachets Of 17.15g

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →